Sionna Therapeutics annual meeting elects three Class I directors, ratifies auditor

Sionna Therapeutics, Inc.

Shareholders elected Joshua Resnick, Bruce Booth, and Lucian Iancovici as Class I directors, each with over 42 million votes for.
Ratification of Deloitte & Touche as independent auditor for FY2025 passed with 43,189,421 votes for, none against.
Record date April 15, 2025; 44,124,394 shares outstanding; broker non-votes of 496,255 on director elections.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.